{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:27:22Z","timestamp":1786688842112,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Oral cholera vaccines (OCVs) show variable immunogenicity in endemic settings. Host factors including enteric dysfunction, systemic inflammation, and nutritional status may influence responses, yet their role in shaping OCV immune responses is not fully understood. This study examined associations between pre-vaccination biomarkers spanning these domains and vibriocidal seroconversion to an OCV, while characterizing how the same biomarker profiles are altered during acute natural\n                      <jats:italic>V. cholerae<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective analysis of stored samples from two Zambian cohorts. The primary cohort comprised 225 adults vaccinated with Shanchol\u2122 IN 2021.The comparator cohort included 38 individuals with acute\n                      <jats:italic>V. cholerae<\/jats:italic>\n                      infection during the 2023 outbreak. Eleven biomarkers were measured using the MEEDAT 11-plex ELISA, and vibriocidal antibodies were assessed. Associations with seroconversion were assessed using cross-fit partialling-out LASSO Poisson regression and quartile analysis. Biomarker profiles were compared between cohorts using Wilcoxon rank-sum and Spearman correlation tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Quartile analysis showed higher seroconversion rates among participants with low to mid-range thyroglobulin levels, while the highest quartile had reduced responses (Inaba Q4: 36.2%; Ogawa Q4: 49.2%). In multivariable LASSO Poisson regression, higher baseline FGF-21 was independently associated with increased Inaba seroconversion (adjusted IRR 1.10, 95% CI 1.04-1.17, p=0.001). Compared with the pre-vaccination baseline, acutely infected individuals exhibited lower ferritin, IGF-1 and RBP4, and higher sTfR, CRP, AGP and FGF-21, together with a restructured inter-biomarker correlation network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Selected pre-vaccination host biomarkers, particularly FGF-21 and thyroglobulin, are associated with OCV seroconversion. The profound multi-domain perturbation observed during acute infection underscores the importance of measuring these markers under stable baseline conditions when studying vaccine immunogenicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1917668","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:33:44Z","timestamp":1786685624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-vaccination biomarkers of enteric dysfunction, inflammation and nutritional status associate with seroconversion to oral cholera vaccine and are perturbed during natural infection"],"prefix":"10.3389","volume":"17","author":[{"given":"Fraser","family":"Liswaniso","sequence":"first","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Phiri","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Department of Epidemiology and Biostatistics, University of Zambia","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwelwa","family":"Chibuye","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Amsterdam University Medical Centers (UMC), location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie C.","family":"Luchen","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Amsterdam Institute of Infection and Immunity, Amsterdam University Medical Centers","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Ngosa","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Ng\u2019ombe","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Centre for Epidemic Response and Innovation, University of Stellenbosch","place":["Stellenbosch, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Chibesa","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutinta","family":"Muchimba","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Chilengi","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Zambia National Public Health Institute (ZNPHI)","place":["Lusaka, Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bosomprah","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Department of Biostatistics, School of Public Health, University of Ghana","place":["Accra, Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Chisenga","sequence":"additional","affiliation":[{"name":"Basic Sciences and Immunology, Centre for Infectious Disease Research in Zambia (CIDRZ)","place":["Lusaka, Zambia"]},{"name":"Parasites and Microbes Programme, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088139","article-title":"Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions","volume":"9","author":"Deen","year":"2014","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262239","article-title":"Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol\u2122) in adults residing in Lukanga Swamps of Zambia","volume":"17","author":"Ng'ombe","year":"2022","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(02)00348-1","article-title":"Calibrated serological techniques demonstrate significantly different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children","volume":"21","author":"Hallander","year":"2002","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.20944\/preprints202402.0582.v1","article-title":"Seroconversion and kinetics of vibriocidal antibodies during the first 90 days of re-vaccination with oral cholera vaccine in an endemic population","volume":"12","author":"Chisenga","year":"2024","journal-title":"Vaccines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2217\/fmb-2017-0128","article-title":"Causes of impaired oral vaccine efficacy in developing countries","volume":"13","author":"Parker","year":"2018","journal-title":"Future Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2018-0016","article-title":"Exploring the relationship between environmental enteric dysfunction and oral vaccine responses","volume":"13","author":"Church","year":"2018","journal-title":"Future Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)60937-x","article-title":"Maternal and child undernutrition and overweight in low-income and middle-income countries","volume":"382","author":"Black","year":"2013","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.11-0743","article-title":"Enteropathies in the developing world: neglected effects on global health","volume":"86","author":"Prendergast","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.614030","article-title":"Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome","volume":"8","author":"De Luca","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4103\/mamcjms.mamcjms_70_22","article-title":"Assessment of Vitamin A Status in Patients with Iron Deficiency Anemia","volume":"9","author":"Aggarwal","year":"2020","journal-title":"MAMC J Med Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3945\/an.115.010215","article-title":"Overview of the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) Project","volume":"7","author":"Suchdev","year":"2016","journal-title":"Adv Nutr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008711","article-title":"Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children","volume":"14","author":"Arndt","year":"2020","journal-title":"PloS NeglTrop Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003881","article-title":"A cholera conjugate vaccine containing O-specific polysaccharide (OSP) of V. cholerae O1 Inaba and recombinant fragment of tetanus toxin heavy chain (OSP:rTTHc) induces serum, memory and lamina proprial responses against OSP and is protective in mice","volume":"9","author":"Sayeed","year":"2015","journal-title":"PloS NeglTrop Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy414","article-title":"Cholera: immunity and prospects in vaccine development","volume":"218","author":"Harris","year":"2018","journal-title":"J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0429","article-title":"Thyroid hormones as modulators of immune activities at the cellular level","volume":"21","author":"De Vito","year":"2011","journal-title":"Thyroid"},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40795-020-00397-w","article-title":"Prevalence of iodine deficiency among pregnant women in Gwembe and Sinazongwe districts of Southern Province, Zambia: a cross-sectional study","volume":"6","author":"Kaile","year":"2020","journal-title":"BMC Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00101.2017","article-title":"Fibroblast growth factor 21: a regulator of metabolic disease and health span","volume":"313","author":"Xie","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1333429","article-title":"Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity","volume":"15","author":"Liang","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293101","article-title":"Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach","volume":"18","author":"Mwila-Kazimbaya","year":"2023","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83075","article-title":"FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis","volume":"12","author":"Liu","year":"2023","journal-title":"eLife"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1053997","article-title":"Emerging roles of fibroblast growth factor 21 in critical disease","volume":"9","author":"Yan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2024.03.013","article-title":"Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells","volume":"36","author":"Hu","year":"2024","journal-title":"Cell Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114408","article-title":"Markers of Environmental Enteric Dysfunction are Associated with Poor Growth and Developmental Outcomes among Young Children in Lusaka, Zambia","volume":"277","author":"Lauer","year":"2025","journal-title":"J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1804281","article-title":"Anemia of inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101173","DOI":"10.2139\/ssrn.3769217","article-title":"Associations between biomarkers of environmental enteric dysfunction and oral rotavirus vaccine immunogenicity in rural Zimbabwean infants","volume":"41","author":"Church","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s1359-6101(98)00022-7","article-title":"Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation","volume":"10","author":"Heemskerk","year":"1999","journal-title":"Cytokine Growth Factor Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/66.2.460s","article-title":"Nutrition and the immune system: an introduction","volume":"66","author":"Chandra","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2736","article-title":"Effect of helminth-induced immunity on infections with microbial pathogens","volume":"14","author":"Salgame","year":"2013","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.09.036","article-title":"Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh","volume":"2","author":"Naylor","year":"2015","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1917668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:33:45Z","timestamp":1786685625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1917668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1917668"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1917668","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1917668"}}